|
End-of-day quote
Nasdaq
2026-09-17
|
5-day change | 1st Jan Change | ||
| 11.63 USD | -0.73% |
|
+1.39% | -21.15% |
| 08-31 | Daxor Corporation Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 07-30 | Daxor Launches Blood Testing Lab in Eastern Kansis | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| DXR | End-of-day quote | |
NYSE
| DXR | Delayed | |
|
CBOE
| DXR | Real-time | |
|
Deutsche Boerse AG
| DX5 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bearish |
| Resistance | 11.72 | 11.72 | 11.48 |
| Spread/Res. | -0.73% | -0.73% | +1.31% |
| Spread/Supp. | +9.20% | +13.24% | +25.59% |
| Support | 10.65 | 10.27 | 9.26 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- DXR Stock
- Charts Daxor Corporation
Select your edition
All financial news and data tailored to specific country editions
